Quantcast

Latest Regeneration Stories

2010-12-28 08:00:00

SAN DIEGO, Dec. 28, 2010 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) today reported that data from the Company's Matrix Phase 2b clinical study has been accepted for publication in the journal, Wound Repair and Regeneration and provided an update on plans for commercialization of its Excellagen formulated collagen topical wound dressing. (Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO) The clinical paper now accepted for publication is titled, "Formulated...

2010-12-21 08:00:00

LITTLETON, Mass., Dec. 21, 2010 /PRNewswire/ --Audax Medical, Inc. (www.audaxmed.com), a privately held medical device company specializing in the development of orthobiologics, has been awarded a research and development grant through the Qualifying Therapeutic Discovery Project (QTDP) program. The QTDP was established under the Patient Protection and Affordable Care Act of 2010 to support therapeutic projects that are innovative, reduce long-term healthcare costs, and/or address unmet...

2010-12-20 02:00:00

MONT-SAINT-GUIBERT, Belgium, December 20, 2010 /PRNewswire/ -- - Pre-Clinical Results Show 70% Reduction in Infarct Size The Belgian biotechnology company, Cardio3 BioSciences, a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiovascular diseases, today announces positive pre-clinical results from its in-house product candidate C3BS-GQR-1, a "cardiopoietic" cocktail designed to treat patients suffering from acute...

2010-12-07 07:30:00

EAST NORRITON, Pa., Dec. 7, 2010 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced that data from the Company's Neo-Kidney Augment(TM), Neo-GI Augment(TM), and Neo-Urinary Conduit(TM) programs are being featured in several posters and oral presentations at the TERMIS North America annual meeting being held December 5-8, in Orlando, Florida. Key data featured include the first presentations on the Neo-Kidney Augment mechanism of action,...

2010-11-23 12:41:37

Researchers in the United States have developed a medical model for regenerating bladders using stem cells harvested from a patient's own bone marrow. The research, published in Stem Cells, is especially relevant for paediatric patients suffering from abnormally developed bladders, but also represents another step towards new organ replacement therapies. The research, led by Drs Arun Sharma and Earl Cheng from the Feinberg School of Medicine at Northwestern University, focused on bone marrow...

2010-11-23 07:30:00

EAST NORRITON, Pa., Nov. 23, 2010 /PRNewswire/ -- Tengion, Inc (Nasdaq: TNGN), a leader in regenerative medicine, today announced that Steven Nichtberger, M.D., President and Chief Executive Officer of Tengion, will present at the upcoming Piper Jaffray 22nd Annual Health Care Conference on Wednesday, December 1, 2010, at 9:30 a.m. EST. A live audio webcast of the presentation can be accessed at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=TNGN&item_id=3494808 or under...

2010-11-17 17:28:36

Study Highlights:     * Ample and viable cardiac stem cells can be isolated from elderly and sick patients with heart disease and diabetes.    * It may be possible to treat heart failure patients with their own stem cells.    * An unrelated study notes that an aging heart can generate new cells at a substantial rate. Cardiac stem cells "” even in elderly and sick patients "” could generate new heart muscle and vessel tissue and be used...

2010-11-12 12:38:21

Weill Cornell Medical College studies lay groundwork for new treatments for regenerating liver and bone marrow The liver's unique ability among organs to regenerate itself has been little understood. Now Weill Cornell Medical College scientists have shed light on how the liver restores itself by demonstrating that endothelial cells -- the cells that form the lining of blood vessels -- play a key role. The results of their study are published today in the online edition of the journal Nature,...

2010-10-27 14:00:00

EAST NORRITON, Pa., Oct. 27 /PRNewswire/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, reviewed pipeline progress at its first Analyst and Investor Meeting which was held today in New York City. The event featured updates and discussions of milestones and key data for the Company's Neo-Urinary Conduit(TM) and Neo-Kidney Augment(TM) programs. An audio archive of the event and presentation materials will be available at the Investors section of the Tengion website...

2010-10-26 07:30:00

EAST NORRITON, Pa., Oct. 26 /PRNewswire-FirstCall/ -- Tengion, Inc. (Nasdaq: TNGN), a leader in regenerative medicine, today announced it will host a conference call and live audio webcast on Monday, November 1, 2010 at 5:00 p.m. EDT to provide a business update and discuss its third quarter 2010 financial results. To participate in the call, please dial 888.713.4213 (domestic) or 617.213.4865 (international) and reference the access code 30673244. This conference call will also be...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related